These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 4446555)

  • 21. Neuraminidase antibody response to inactivated influenza virus vaccine following intranasal and intramuscular vaccination.
    Muhamed G; Greenbaum E; Zakay-Rones Z
    Isr Med Assoc J; 2006 Mar; 8(3):155-8. PubMed ID: 16599048
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibody against influenza A2 virus neuraminidase in human sera.
    Schild GC
    J Hyg (Lond); 1969 Jun; 67(2):353-65. PubMed ID: 5256462
    [No Abstract]   [Full Text] [Related]  

  • 23. Comparison of the anti-neuraminidase antibody responses to vaccination with influenza whole particle and hemagglutinin vaccines.
    Hiromatsu Y; Sato Y; Inokuchi T; Umeno H; Kurosawa Y; Ishii K; Kobayashi K; Kaji M; Shingu T; Hayashida K
    Kurume Med J; 1984; 31(3):197-202. PubMed ID: 6536804
    [No Abstract]   [Full Text] [Related]  

  • 24. Antibody response to influenza vaccination in healthy adults.
    Brydak LB; Tadeusz S; Magdalena M
    Viral Immunol; 2004; 17(4):609-15. PubMed ID: 15671759
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influenza viral neuraminidase: the forgotten antigen.
    Johansson BE; Cox MM
    Expert Rev Vaccines; 2011 Dec; 10(12):1683-95. PubMed ID: 22085172
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Use of the elution inhibition reaction for detecting antineuraminidase antibodies in the sera of persons inoculated with inactivated influenza vaccine].
    Briantseva EA
    Tr Inst Im Pastera; 1982; 59():59-62. PubMed ID: 6764988
    [No Abstract]   [Full Text] [Related]  

  • 27. [Role of antineuraminidase antibodies in the human immunological response to the administration of live type A influenza vaccines].
    Naĭkhin AN; Topuriia NV; Denisov GM
    Mikrobiol Zh (1978); 1980; 42(5):642-5. PubMed ID: 7432210
    [No Abstract]   [Full Text] [Related]  

  • 28. The antibody response and immunity to challenge infection induced by whole, inactivated and tween-ether split influenza vaccines.
    Potter CW; Jennings R; Clark A
    Dev Biol Stand; 1977 Jun 1-3; 39():323-8. PubMed ID: 604115
    [No Abstract]   [Full Text] [Related]  

  • 29. Assessment of immunity to influenza using artifical challenge of normal volunteers with influenza virus.
    Couch RB
    Dev Biol Stand; 1975; 28():295-306. PubMed ID: 1126573
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety, immunogenicity and infectivity of new live attenuated influenza vaccines.
    Isakova-Sivak I; Rudenko L
    Expert Rev Vaccines; 2015; 14(10):1313-29. PubMed ID: 26289975
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical trials with a new influenza subunit vaccine in adults and children.
    Kunz C; Hofmann H; Bachmayer H; Liehl E; Moritz AJ
    Dev Biol Stand; 1977 Jun 1-3; 39():297-302. PubMed ID: 342311
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Epidemiologic evaluation and labroatory characteristics of live influenza tissue vaccine for oral use].
    Mitchenko VP; Buruikova VI; Zharkova LD; Zakladnaia ZM; Poddubnyĭ FN
    Zh Mikrobiol Epidemiol Immunobiol; 1974; 00(5):49-52. PubMed ID: 4454883
    [No Abstract]   [Full Text] [Related]  

  • 33. [Effect of multiple vaccination against influenza on the specificity of humoral immunity].
    Iagodovskiĭ VV; Slepushkin AN; Schastnyĭ EI; Fedorova GI
    Vopr Virusol; 1986; 31(3):300-3. PubMed ID: 3765556
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-neuraminidase antibody response after administration of a split influenza vaccine.
    Constantinescu C; Ioniţă E; Alexandrescu V; Maţepiuc M; Creţescu L; Niculescu IT
    Arch Roum Pathol Exp Microbiol; 1985; 44(1):37-41. PubMed ID: 4038049
    [No Abstract]   [Full Text] [Related]  

  • 35. [Role of antineuraminidase antibodies in protection against influenza].
    Aymard M; Gerentes L; Kessler N
    Bull Acad Natl Med; 1998; 182(8):1723-36; discussion 1736-7. PubMed ID: 10188318
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recent advances in influenza vaccinces.
    Gregg MB
    J Occup Med; 1974 Oct; 16(10):651-3. PubMed ID: 4616070
    [No Abstract]   [Full Text] [Related]  

  • 37. Levels of immunoglobulins and antibodies to haemaglutinin and neuraminidase of influenza virus in nasal secretions after natural infection.
    Hrusková J; Syrůcek L; Tůmová B; Stumpa A; Brůcková M; Losová M; Berkovicová V
    Acta Virol; 1976 Apr; 20(2):126-34. PubMed ID: 5867
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Seroconversion of antihemagglutinins into immunoglobulin fractions of different classes following vaccination with inactivated influenza vaccine].
    Leĭbenzon AS
    Lab Delo; 1984; (7):408-9. PubMed ID: 6207346
    [No Abstract]   [Full Text] [Related]  

  • 39. [Antibody response to anti-influenza vaccination with A2-Hong Kong-68 and B-Roma-1-67 bivalent vaccine].
    Dal Fabbro G; Valletta G; Frugoni G; Ricciardi-Tenore N
    Minerva Med; 1972; 63(38):2167-71. PubMed ID: 4664783
    [No Abstract]   [Full Text] [Related]  

  • 40. [Strain specificity of the antineuraminidase antibodies of influenza virus serotype N2 strains in convalescents].
    Molibog EV; Konstantinov-Zibelist I; Starke G; Zakstel'skaia LIa
    Vopr Virusol; 1979; (6):631-4. PubMed ID: 524860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.